These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 19304531)
1. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line]. Yan F; Wang XM; Pan C Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):483-6. PubMed ID: 19304531 [TBL] [Abstract][Full Text] [Related]
2. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics]. Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913 [TBL] [Abstract][Full Text] [Related]
3. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure]. Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):95-8. PubMed ID: 14980111 [TBL] [Abstract][Full Text] [Related]
4. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma]. Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842 [TBL] [Abstract][Full Text] [Related]
5. [An experimental study of recombinant adenovirus microsphere carrying antisense multidrug resistance-associated protein gene for reversing MRP of hepatocellular carcinoma in vitro]. Yu SH; Yan LN; Zhang Y; Gou XH; Han L; Chen YB Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):471-4. PubMed ID: 16078563 [TBL] [Abstract][Full Text] [Related]
6. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341 [TBL] [Abstract][Full Text] [Related]
7. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188 [TBL] [Abstract][Full Text] [Related]
8. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma. Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956 [TBL] [Abstract][Full Text] [Related]
9. Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells. Li YX; Lin ZB; Tan HR Acta Pharmacol Sin; 2004 Jan; 25(1):76-82. PubMed ID: 14704126 [TBL] [Abstract][Full Text] [Related]
10. [Effect of neferine on adriamycin-resistance of thermotolerant hepatocarcinoma cell line HepG2/thermotolerance]. Ai XH; Tang XQ; Liu YP; Liu HQ; Dong L Ai Zheng; 2007 Apr; 26(4):357-60. PubMed ID: 17430651 [TBL] [Abstract][Full Text] [Related]
11. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. Lu F; Hou YQ; Song Y; Yuan ZJ Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179 [TBL] [Abstract][Full Text] [Related]
12. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU]. Tang HH; Zhou M; Liang G Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects and in vitro reversal of multidrug resistance by therapeutic ultrasound in human hepatocarcinoma cell line (HepG2). Shao ZY; Zhai BJ; Zhao CL; Hu K; Shen DM; Wu F Ultrasonics; 2008 Aug; 48(4):297-302. PubMed ID: 18199465 [TBL] [Abstract][Full Text] [Related]
14. [MDR-reversing effect of two components of catechin on human hepatocellular carcinoma BEL-7404/Adr in vitro]. Liang G; Zhang S; Huang ZM; Tang AZ Ai Zheng; 2004 Apr; 23(4):401-5. PubMed ID: 15087027 [TBL] [Abstract][Full Text] [Related]
15. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance. Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289 [TBL] [Abstract][Full Text] [Related]
16. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w. Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305 [TBL] [Abstract][Full Text] [Related]
17. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line. Han Y; Bu LM; Ji X; Liu CY; Wang ZH Chin J Dig Dis; 2005; 6(2):82-6. PubMed ID: 15904426 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines. Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484 [TBL] [Abstract][Full Text] [Related]
19. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells. Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051 [TBL] [Abstract][Full Text] [Related]
20. [Down regulation of mitogen activated protein kinase phosphatase-1 mediate acquired multidrug resistance in pancreatic adenocarcinoma cell line SW1990/Fu]. Guo JC; Zhao YP; Liao Q; Chen G; Zhu Y Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):473-5. PubMed ID: 16772084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]